Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Star
6025.5000 65.00 (1.09%)
NSE May 09, 2025 15:31 PM
Volume: 450.0K
 

6025.50
1.09%
Axis Direct
While Divis reported 11% YoY decline in Q2 revenue (19% YoY decline in Q1), it exhibited 8% QoQ growth as most plant protocols and procedures (leading to manufacturing disruption) suggested in remediation plan were completed in Q1.
Divi's Laboratories Ltd. is trading above all available SMAs
More from Divi's Laboratories Ltd.
Recommended